BSPM - Biostar Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
271.25k
Enterprise Value 3
2.46M
Trailing P/E
0.44
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.85
Price/Book (mrq)
0.01
Enterprise Value/Revenue 3
7.73
Enterprise Value/EBITDA 6
0.63

Trading Information

Stock Price History

Beta (5Y Monthly) 2.18
52-Week Change 3-60.23%
S&P500 52-Week Change 324.46%
52 Week High 30.5000
52 Week Low 30.1000
50-Day Moving Average 30.1297
200-Day Moving Average 30.1795

Share Statistics

Avg Vol (3 month) 36.51k
Avg Vol (10 day) 34.3k
Shares Outstanding 52.64M
Float 2.21M
% Held by Insiders 116.19%
% Held by Institutions 10.59%
Shares Short (Aug 31, 2018) 4194.89k
Short Ratio (Aug 31, 2018) 43
Short % of Float (Aug 31, 2018) 4N/A
Short % of Shares Outstanding (Aug 31, 2018) 46.46%
Shares Short (prior month Jul 31, 2018) 4246.69k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 27/1
Last Split Date 3Feb 5, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 294.01%
Operating Margin (ttm)876.46%

Management Effectiveness

Return on Assets (ttm)4.25%
Return on Equity (ttm)2.66%

Income Statement

Revenue (ttm)317.79k
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)915.17k
EBITDA 3.89M
Net Income Avi to Common (ttm)934.35k
Diluted EPS (ttm)0.3400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)364.97k
Total Cash Per Share (mrq)0.14
Total Debt (mrq)2.43M
Total Debt/Equity (mrq)6.71
Current Ratio (mrq)0.19
Book Value Per Share (mrq)13.71

Cash Flow Statement

Operating Cash Flow (ttm)8.59M
Levered Free Cash Flow (ttm)7.47M